Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study - Takeaways - MDSpire

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study

  • By

  • Christina Liu

  • Frida Renström

  • Giacomo Gastaldi

  • Michael Brändle

  • Stefan Bilz

  • May 29, 2026

  • 0 min

Share

  • 1

    The SwissDiab study evaluated lipid management in type 1 diabetes mellitus patients according to the 2021 European Society of Cardiology guidelines.

  • 2

    Among 216 patients, 75% were at high cardiovascular risk, and only 33.6% were prescribed lipid-lowering therapy.

  • 3

    LDL-C target attainment was poor at 11.6%, while non-HDL-C and apoB targets were reached by 30.6% and 59.7% of patients, respectively.

  • 4

    Only 11.1% of patients achieved all three lipid targets, while 39.8% did not meet any of the lipid targets.

  • 5

    The study highlights the discordance in target attainment across lipid biomarkers, impacting clinical decision-making in T1DM management.

Original Source(s)

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study

  • by Christina Liu, Frida Renström, Giacomo Gastaldi, Michael Brändle, Stefan Bilz

  • May 29, 2026

Related Content

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”

  • February 9, 2026

Correlation of Triglyceride-Glucose Index with Diabetic Retinopathy in Diabetic Patients in Nepal: A Cross-Sectional Analysis